Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2022-10-18 2022-10-08
Drug Identification Number 00893560 00893560
Brand name ALOMIDE ALOMIDE
Common or Proper name ALOMIDE SOLUTION ALOMIDE SOLUTION
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients LODOXAMIDE LODOXAMIDE
Strength(s) 0.1% 0.1%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 10 ML 10 ML
ATC code S01GX S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-10-07 2022-10-07
Actual start date 2022-10-17
Estimated end date 2022-11-04 2022-11-04
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments